iCAD's revenue decline in Q3

Michael Bassett | | Health Exec | Precision Medicine
iCAD reported a drop of in revenue in the third quarter of 2009, which ended Sept. 30.

The Nashua, N.H.-based company posted total revenue of 7.1 million in the third quarter, more than $4 million less than the $11.2 million reported in the same quarter a year ago. Net income for the quarter was $113,000, compared to the $2.1 million posted in the third quarter of 2008.

iCAD, a provider of image analysis and workflow solutions, reported $4.8 million in digital computer-aided detection (CAD) and MRI revenue in the third quarter, down from the $8.2 million posted in the year-ago quarter. Film-based revenue declined to $1.3 million from $2.2 million a year ago.

Michael Bassett,

Contributor

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."